08:55 AM EDT, 08/28/2025 (MT Newswires) -- Health care stocks were edging higher premarket Thursday, with the Health Care Select Sector SPDR Fund (XLV) slightly advancing and the iShares Biotechnology ETF (IBB) up 0.7%.

Celcuity ( CELC ) stock was more than 10% higher after the company said the US Food and Drug Administration has agreed to review its new drug application for gedatolisib under the Real-Time Oncology Review program for treating HR+/HER2- advanced breast cancer.